Hokkaido University and Hitachi, Ltd. have announced that the approval under Japan’s Pharmaceutical Affairs Law has been granted to Hitachi for the manufacture and sales of the PROBEAT-RT, a proton beam therapy treatment system combining spot scanning irradiation and Real-time Tumor-tracking Radiation Therapy.

See more here:
The PROBEAT-RT Proton Beam Therapy System incorporating real-time tumor-tracking is approved in Japan

Scroll to Top